Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,148.00
Bid: 3,156.00
Ask: 3,158.00
Change: 42.00 (1.35%)
Spread: 2.00 (0.063%)
Open: 3,132.00
High: 3,166.00
Low: 3,106.00
Prev. Close: 3,106.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Oct 2019 16:00

RNS Number : 9176Q
Bunzl PLC
23 October 2019
 

Notification of transactions by person discharging managerial responsibilities

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Brian May

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bunzl plc

b)

 

LEI

 

 

213800Q1Q9DV4L78UM09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 10,202 shares at nil cost following the exercise of an award granted in April 2016 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 4,807 shares at £18.96 per share to cover the costs of exercise, including tax and dealing costs. As a result of these transactions, Brian May's shareholding has increased by 5,395 shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£18.96

4,807

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2019-10-22

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 5,983 shares at nil cost following the exercise of an award granted in October 2016 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 2,820 shares at £18.96 per share to cover the costs of exercise, including tax and dealing costs. As a result of these transactions, Brian May's shareholding has increased by 3,163 shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£18.96

2,820

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A single transaction

 

N/A

 

e)

 

Date of the transaction

 

 

2019-10-22

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 3

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 1,197 shares at an option price of £12.53 per share following the exercise of options granted in March 2014 under the Bunzl plc UK Sharesave Scheme (2011). As a result of this transaction, Brian May's shareholding has increased by 1,197 shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Option price of £12.53 per share

1,197

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A single transaction

 

N/A

 

e)

 

Date of the transaction

 

 

2019-10-22

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Notification of transactions by person discharging managerial responsibilities

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Frank van Zanten

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bunzl plc

b)

 

LEI

 

 

213800Q1Q9DV4L78UM09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 11,714 shares at nil cost following the exercise of an award granted in October 2016 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 5,423 shares at £19.47678 per share to cover the costs of exercise, including tax and dealing costs. As a result of these transactions, Frank van Zanten's shareholding has increased by 6,291 shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£19.47678

5,423

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2019-10-23

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZXLFLKBFZFBV
Date   Source Headline
1st Mar 20234:02 pmRNSDirector/PDMR Shareholding
27th Feb 20232:00 pmRNSDividend Declaration
27th Feb 20237:00 amRNSFinal Results
27th Feb 20237:00 amRNSAcquisition
7th Feb 20237:00 amRNSDirectorate Change
6th Feb 20232:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSCUSTOMER CONTRACT
1st Feb 202310:19 amRNSTotal Voting Rights
10th Jan 20233:44 pmRNSDirector/PDMR Shareholding
6th Jan 20234:07 pmRNSDirector/PDMR Shareholding
5th Jan 20235:36 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSTrading Statement
20th Dec 20227:00 amRNSAcquisition
14th Dec 20228:00 amRNSAdditional Listing
8th Dec 202212:56 pmRNSHolding(s) in Company
5th Dec 20229:45 amRNSDirector/PDMR Shareholding
1st Dec 20222:34 pmRNSTotal Voting Rights
29th Nov 20223:21 pmRNSDirector/PDMR Shareholding
11th Nov 20229:00 amRNSPublication of Admission Particulars
4th Nov 202212:08 pmRNSDirector/PDMR Shareholding
2nd Nov 20224:20 pmRNSDirector/PDMR Shareholding
1st Nov 20223:00 pmRNSTotal Voting Rights
1st Nov 202210:00 amRNSBlock listing Interim Review
20th Oct 20227:00 amRNSTrading Statement
11th Oct 20227:00 amRNSInvestor event
7th Oct 20224:11 pmRNSDirector/PDMR Shareholding
4th Oct 20224:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20223:13 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSHolding(s) in Company
7th Sep 202210:59 amRNSDirector/PDMR Shareholding
1st Sep 202211:08 amRNSTotal Voting Rights
31st Aug 20221:46 pmRNSDirector/PDMR Shareholding
30th Aug 202210:00 amRNSDividend Declaration
30th Aug 20227:00 amRNSHalf-year Report
4th Aug 20229:19 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSAcquisition
1st Aug 20223:07 pmRNSTotal Voting Rights
1st Aug 202210:00 amRNSDirector Declaration
29th Jul 20227:00 amRNSAppointment of Joint Corporate Broker
19th Jul 20227:00 amRNSDirectorate Change
12th Jul 202210:32 amRNSDirector/PDMR Shareholding
6th Jul 20225:12 pmRNSDirector/PDMR Shareholding
1st Jul 20222:18 pmRNSTotal Voting Rights
30th Jun 20227:00 amRNSTrading Statement
14th Jun 20227:00 amRNSAcquisition
8th Jun 202212:44 pmRNSDirector/PDMR Shareholding
1st Jun 202210:42 amRNSTotal Voting Rights
11th May 20228:00 amRNSAdditional Listing
5th May 202211:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.